Bleeding complications of unfractionated heparin

Bibliography

• Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:188S-203S
   PubMed Web of Science ®Google Scholar
• Melloni C, Alexander KP, Chen AY, Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes. Am Heart J 2008;156:209-15
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Mehta SR, Anand SS, Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006;114:774-82
   PubMed Web of Science ®Google Scholar
• Kitchen S. Problems in laboratory monitoring of heparin dosage. Br J Haematol 2000;111:397-406
   PubMed Web of Science ®Google Scholar
• Brill-Edwards P, Ginsberg JS, Johnston M, Hirsh J. Establishing a therapeutic range for heparin therapy. Ann Intern Med 1993;119:104-9
   PubMed Web of Science ®Google Scholar
• Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-7
   PubMed Web of Science ®Google Scholar
• Cruickshank MK, Levine MN, Hirsh J, A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7
   PubMed Web of Science ®Google Scholar
• Hull RD, Raskob GE, Rosenbloom D, Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95
   PubMed Web of Science ®Google Scholar
• Raschke RA, Reilly BM, Guidry JR, The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 1993;119:874-81
   PubMed Web of Science ®Google Scholar
• Hochman JS, Wali AU, Gavrila D, A new regimen for heparin use in acute coronary syndromes. Am Heart J 1999;138:313-18
   PubMed Web of Science ®Google Scholar
• Becker RC, Ball SP, Eisenberg P, A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. Am Heart J 1999;137:59-71
   PubMedGoogle Scholar
• Anand SS, Yusuf S, Pogue J, Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin. Circulation 2003;107:2884-8
   PubMed Web of Science ®Google Scholar
• Cheng S, Morrow DA, Sloan S, Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation 2009;119:1195-202
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, Bates ER, Hochman JS, Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial. Eur Heart J 2005;26:1506-12
   PubMed Web of Science ®Google Scholar
• Newby LK, Harrington RA, Bhapkar MV, An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A. J Thromb Thrombolysis 2002;14:33-42
   PubMed Web of Science ®Google Scholar
• Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial. Circulation 1996;94:911-21
   PubMed Web of Science ®Google Scholar
• Krishnaswamy A, Lincoff AM, Cannon CP. The use and limitations of unfractionated heparin. Crit Pathw Cardiol 2010;9:35-40
   PubMedGoogle Scholar
• Menon V, Berkowitz SD, Antman EM, New heparin dosing recommendations for patients with acute coronary syndromes. Am J Med 2001;110:641-50
   PubMed Web of Science ®Google Scholar
• Granger CB, Hirsch J, Califf RM, Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation 1996;93(5):870-8
   PubMed Web of Science ®Google Scholar
• Bonello L, de Labriolle A, Roy P, Head-to-head comparison of bivalirudin versus heparin without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction undergoing primary angioplasty. Cardiovasc Revasc Med 2009;10:156-61
   PubMedGoogle Scholar
• The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82
   PubMed Web of Science ®Google Scholar
• Ferguson JJ, Califf RM, Antman EM, Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004;292:45-54
   PubMed Web of Science ®Google Scholar
• Rao SV, O'Grady K, Pieper KS, A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006;47:809-16
   PubMed Web of Science ®Google Scholar
• Stone GW, Witzenbichler B, Guagliumi G, Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Atar D. Assessment of bleeding events in clinical trials–proposal of a new classification. Am J Cardiol 2007;99:288-90
   PubMed Web of Science ®Google Scholar
• Alexander KP, Chen AY, Roe MT, Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA 2005;294:3108-16
   PubMed Web of Science ®Google Scholar
• Wang TY, Chen AY, Alexander KP, Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction. Am J Med 2008;121:805-10
   PubMed Web of Science ®Google Scholar
• Spinler SA, Mahaffey KW, Gallup D, Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY. Int J Cardiol 2009. [Epub ahead of print]
   Google Scholar
• Yusuf S, Zhao F, Mehta SR, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15
   PubMed Web of Science ®Google Scholar
• Kastrati A, Neumann FJ, Mehilli J, Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008;359:688-96
   PubMed Web of Science ®Google Scholar
• Rao SV, Jollis JG, Harrington RA, Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Giugliano RP, Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-9
   PubMed Web of Science ®Google Scholar
• Perrotta PL, Snyder EL. Non-infectious complications of transfusion therapy. Blood Rev 2001;15:69-83
   PubMed Web of Science ®Google Scholar
• Becker RC, Cyr J, Corrao JM, Ball SP. Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience. Am Heart J 1994;128:719-23
   PubMed Web of Science ®Google Scholar
• Zabel KM, Granger CB, Becker RC, Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: results of GUSTO-I. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Am Heart J 1998;136:868-76
   PubMedGoogle Scholar
• Cannon CP, Dingemanse J, Kleinbloesem CH, Automated heparin-delivery system to control activated partial thromboplastin time: evaluation in normal volunteers. Circulation 1999;99:751-6
   PubMed Web of Science ®Google Scholar
• Hicks JM, Haeckel R, Price CP, Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 2001;303:1-17
   PubMed Web of Science ®Google Scholar